Atlas Arteria reiterates ‘reject’ on IFM bid, maintains 2026 distribution guidance

The Atlas Arteria Group (ASX: ALX) share price is in focus today after the company released its second supplementary target’s statement, reiterating that securityholders should reject the takeover offer from IFM’s Diamond Infraco 1 Pty Ltd. Key points include confirmation of a 40c per security distribution guidance for 2026 and the continued unanimous recommendation by independent directors to reject the offer.

What did Atlas Arteria report?

• The offer period for IFM’s off-market takeover bid has been extended by one week, now closing at 7.00pm (Sydney) on 18 June 2026.
• Atlas Arteria maintains guidance for an ordinary distribution of 40.0 cents per security in 2026.
• The independent directors continue to recommend that securityholders reject the $4.75 and $5.10 per security offers.
• No announced increase in the bidder’s voting power since extension; acceptances remain low.
• The bidder has not satisfied or waived any of the extensive conditions set out in its offer.

What else do investors need to know?

The company’s second supplementary target’s statement was released in response to the Fourth Supplementary Bidder’s Statement from IFM. The Board states there is no urgency for securityholders to accept the bid, as IFM must give notice of its offer conditions at least seven days before closure.

Atlas Arteria confirms that the proceeds from any asset sales would be available to be returned to securityholders, in addition to its regular distribution schedule. The company encourages investors to seek independent financial advice and read all issued statements and expert reports before making decisions regarding the offer.

What’s next for Atlas Arteria?

Atlas Arteria’s directors restate their confidence in the company’s long-term value, urging securityholders to remain patient. The company has emphasised ongoing discipline in capital management, pledging returns to securityholders through regular and special distributions as circumstances permit.

With the offer period extended, investors will have advance notice if the bid becomes unconditional. The Board will continue to keep shareholders updated as developments unfold in the takeover process.

Atlas Arteria share price snapshot

Over the past 12 months, Atlas Arteria shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

View Original Announcement

The post Atlas Arteria reiterates ‘reject’ on IFM bid, maintains 2026 distribution guidance appeared first on The Motley Fool Australia.

More reading

• Perpetual to acquire Interfi majority stake; debt reduction underway
• Megaport completes $518m institutional entitlement offer
• Monadelphous Group wins $380m energy contract
• Meridian Energy: draft approval for Lake PÅ«kaki hydro storage
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.